Helius Medical Company Insiders

HSDT Stock  USD 0.51  0  0.31%   
Helius Medical's insiders are aggressively buying. The analysis of insiders' sentiment of trading Helius Medical Technologies stock suggests that vertually all insiders are extremely bullish at this time. Helius Medical employs about 22 people. The company is managed by 6 executives with a total tenure of roughly 19 years, averaging almost 3.0 years of service per executive, having 3.67 employees per reported executive.
Dane Andreeff  CEO
CEO President

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2023-12-14Dane AndreeffAcquired 5000 @ 8.1View
2023-11-30Dane AndreeffAcquired 2000 @ 6.37View
2023-08-30Dane AndreeffAcquired 5000 @ 7.64View
2023-08-28Dane AndreeffAcquired 5078 @ 6.37View
2022-12-16Dane AndreeffAcquired 1600 @ 12.5View
2022-11-22Dane AndreeffAcquired 200 @ 14View
2022-09-12Dane AndreeffAcquired 177 @ 27View
2022-08-24Dane AndreeffAcquired 504 @ 32.5View
Monitoring Helius Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Helius Medical Management Team Effectiveness

The company has return on total asset (ROA) of (1.1256) % which means that it has lost $1.1256 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.598) %, meaning that it created substantial loss on money invested by shareholders. Helius Medical's management efficiency ratios could be used to measure how well Helius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.09 in 2025. Return On Capital Employed is likely to drop to -2.02 in 2025. At this time, Helius Medical's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 384.8 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.6 M in 2025.
Common Stock Shares Outstanding is likely to drop to about 519.7 K in 2025. Net Loss is likely to drop to about (13.3 M) in 2025

Helius Medical Workforce Comparison

Helius Medical Technologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,217. Helius Medical claims roughly 22.0 in number of employees contributing just under 2% to equities under Health Care industry.

Helius Medical Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Helius Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Helius Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Helius Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Helius Medical Notable Stakeholders

A Helius Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Helius Medical often face trade-offs trying to please all of them. Helius Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Helius Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dane AndreeffCEO PresidentProfile
Jeffrey CPATreasurer, CFOProfile
Brian BaptyVP of Strategy and Bus. Devel.Profile
CPA CPATreasurer, CFOProfile
Lawrence PiccianoQuality EngineeringProfile
Antonella MDChief OfficerProfile

About Helius Medical Management Performance

The success or failure of an entity such as Helius Medical Techn often depends on how effective the management is. Helius Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Helius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Helius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.04)(1.09)
Return On Capital Employed(1.92)(2.02)
Return On Assets(1.04)(1.09)
Return On Equity(3.39)(3.56)
Please note, the imprecision that can be found in Helius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Helius Medical Technologies. Check Helius Medical's Beneish M Score to see the likelihood of Helius Medical's management manipulating its earnings.

Helius Medical Workforce Analysis

Traditionally, organizations such as Helius Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Helius Medical within its industry.

Helius Medical Manpower Efficiency

Return on Helius Medical Manpower

Revenue Per Employee29.3K
Revenue Per Executive107.3K
Net Loss Per Employee402.3K
Net Loss Per Executive1.5M
Working Capital Per Employee252.7K
Working Capital Per Executive926.5K

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.